Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
29.35%
20%
—
—
80%
—
5 Years
Score—
Net Growth29.35%
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev Trend80%
Revenue Consistency—
BioXcel Therapeutics Inc fundamental performance
Across BioXcel Therapeutics Inc's full reported history, from 2018 to 2025, revenue grew from $ 0.00 to $ 642K and net income went from -$ 19M to -$ 69M. Revenue increased in 63% of the years measured; net income in 13%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.06 | — |
1 Year2025-08-12 | $ 6.80 | -84.41% |
5 Years2021-08-12 | $ 412.00 | -99.74% |
All Time2018-03-08 | $ 176.48 | -99.40% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2018-03-08 |
|---|---|---|---|---|
| Price | $ 1.06 | $ 6.80 | $ 412.00 | $ 176.48 |
| Return | — | -84.41% | -99.74% | -99.40% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 680K | -$ 75M | $ 17M |
| 2025 | $ 642K | -$ 69M | $ 28M |
| 2024 | $ 2M | -$ 59M | $ 29M |
| 2023 | $ 1M | -$ 179M | $ 65M |
| 2022 | $ 375K | -$ 165M | $ 193M |
| 2021 | $ 0.00 | -$ 106M | $ 232M |
| 2020 | $ 24.00 | -$ 82M | $ 213M |
| 2019 | $ 0.00 | -$ 32M | $ 32M |
| IPO2018 | $ 0.00 | -$ 19M | $ 42M |
Explore beyond BTAI
You're looking at BioXcel Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
